|Número de publicación||US9604047 B2|
|Tipo de publicación||Concesión|
|Número de solicitud||US 13/964,542|
|Fecha de publicación||28 Mar 2017|
|Fecha de presentación||12 Ago 2013|
|Fecha de prioridad||31 Jul 2003|
|También publicado como||EP1656179A1, EP1656179B1, US7914502, US8100868, US8529524, US20050038397, US20110046573, US20120157933, US20130331800, WO2005011799A1|
|Número de publicación||13964542, 964542, US 9604047 B2, US 9604047B2, US-B2-9604047, US9604047 B2, US9604047B2|
|Inventores||Brian L. Newton, Andrew L. Cote, Sr., Charles F. Ganem, David B. Woyak, Richard T. Boisjoly|
|Cesionario original||Np Medical Inc.|
|Exportar cita||BiBTeX, EndNote, RefMan|
|Citas de patentes (189), Otras citas (2), Clasificaciones (7), Eventos legales (1)|
|Enlaces externos: USPTO, Cesión de USPTO, Espacenet|
This application is a continuation of U.S. patent application Ser. No. 13/330,937, entitled “Anti-Drawback Medical Valve,” filed Dec. 20, 2011, and naming Brian L. Newton, Andrew L. Cote Sr., Charles F. Ganem, David B. Woyak, and Richard T. Boisjoly as inventors, the disclosure of which is incorporated herein, in its entirety, by reference.
U.S. patent application Ser. No. 13/330,937, in turn, claims priority from U.S. patent application Ser. No. 12/915,691, now U.S. Pat. No. 8,100,868, entitled “Anti-Drawback Medical Valve,” filed Oct. 29, 2010, and naming Brian L. Newton, Andrew L. Cote Sr., Charles F. Ganem, David B. Woyak, and Richard T. Boisjoly as inventors, the disclosure of which is incorporated herein, in its entirety, by reference.
U.S. patent application Ser. No. 12/915,691, in turn, claims priority from U.S. patent application Ser. No. 10/895,638, now U.S. Pat. No. 7,914,502, entitled “Anti-Drawback Medical Valve,” filed Jul. 21, 2004, and naming Brian L. Newton, Andrew L. Cote Sr., Charles F. Ganem, David B. Woyak, and Richard T. Boisjoly as inventors, the disclosure of which is incorporated herein, in its entirety, by reference.
U.S. patent application Ser. No. 10/895,638, in turn, claims priority from the following provisional United States patent applications, the disclosures of which are incorporated herein, in their entireties, by reference:
The invention generally relates to medical valves and, more particularly, the invention relates to substantially eliminating fluid drawback in a medical valve.
In general terms, medical valving devices often act as a sealed port that may be repeatedly accessed to non-invasively inject fluid into (or withdraw fluid from) a patient's vasculature. Consequently, a medical valve permits the patient's vasculature to be freely accessed without requiring such patient's skin be repeatedly pierced by a needle.
To those ends, as a preliminary step, medical personnel insert a syringe into a medical valve that is appropriately secured to a patient. For example, the valve may be coupled to a catheter having an opposite end secured within the patient's vain. Once inserted, fluid may be freely injected into or withdrawn from the patient. Problems arise, however, when the syringe is withdrawn from the valve. Specifically, a back pressure (i.e., a proximally directed pressure) produced by the withdrawing syringe undesirably can cause blood to be drawn proximally into the valve (e.g., via an attached catheter). In addition to coagulating and impeding the mechanical operation of the valve, blood in the valve (or in the catheter) also compromises its sterility.
In accordance with one aspect of the invention, a gland member within a medical valve is configured to have a substantially consistent or enlarging internal volume as the valve transitions from a closed mode to an open mode. To that end, the valve has a housing forming an interior containing a flow path, and a stationary post member within the interior. The post member has a lumen that is a part of the flow path. The lumen has an opening to the interior of the housing. The valve further includes a gland member circumscribing the post member to produce a variable volume region formed at least in part between the gland member itself and the post member. In addition, the variable volume region is a part of the flow path, while the gland member occludes the post lumen opening when in the closed mode. The variable volume region has an open volume (i.e., when the valve is in the open mode) that is no less than its closed volume (i.e., when the valve is in the closed mode).
In some embodiments, the variable volume region is closed when in the closed mode. Moreover, the gland member may move radially outwardly as the valve transitions from the closed mode toward the open mode. In such case, the radial outward motion may substantially unocclude the opening to the post member lumen.
To provide an anti-drawback effect, the open volume may be greater than or substantially equal to the closed volume. In some embodiments, the gland member has a proximal end that is substantially flush with or extends proximally of a proximal port of the housing. To provide a second reusable seal, the proximal end of the gland may have a slit.
The gland member also may have a sealing ridge that occludes the post lumen opening when in the closed mode. Moreover, the gland member may include a main wall section and a lobed portion. The main wall thickness is greater than the lobe portion wall thickness. In fact, the lobed portion may extend radially outwardly from the main wall section. The lobed portion may move radially outwardly as the valve moves toward the open mode.
In various embodiments, when in the closed mode, the variable volume region is bounded by the post member and the gland member only. To provide an anti-drawback effect, the flow path illustratively has a total volume that varies as the variable volume region varies. For example, the flow path total volume may increase as the volume of the variable volume region increases.
In accordance with another aspect of the invention, a medical valve has a housing forming an interior, and a stationary post member within the interior. The post has a lumen for channeling fluid through the interior. The valve also has a gland member within the interior of the housing. The gland member forms a variable volume region that also is bounded by the post member. The gland member occludes the lumen when in the closed mode. The variable volume region has a closed volume when in the closed mode and an open volume when in the open mode. The open volume is no less than the closed volume.
In accordance with another aspect of the invention, a medical valve has a housing forming both an interior and a distal port. The valve also has a gland member within the interior of the housing. The gland member has a main portion and a protruding portion that together form a variable volume region. The protruding portion protrudes radially outwardly relative to the main portion. Moreover, the protruding portion is defined by a protruding wall, while the main portion is defined by a main wall portion. The protruding wall has a thickness that is less than the thickness of the main wall. In a manner similar to other aspects, the variable volume region has a closed volume when in the closed mode and an open volume when in the open mode. The open volume is no less than the closed volume to substantially prevent net fluid drawback into the interior through the distal port. In other words, during a substantially complete stroke of the valve from the open mode to the closed mode, the total amount of drawn back fluid remaining in the valve should be no greater than about zero microliters.
The foregoing and advantages of the invention will be appreciated more fully from the following further description thereof with reference to the accompanying drawings wherein:
In illustrative embodiments of the invention, a medical valve is configured to substantially eliminate fluid drawback when a nozzle or syringe is withdrawn from it. Specifically, in one such embodiment, the medical valve produces neither a net negative nor a net positive pressure when a nozzle or syringe is withdrawn. Consequently, after the nozzle is withdrawn, the net fluid expelled from or drawn into the valve is substantially equal to zero.
To these ends, illustrative embodiments of the medical valve have a fluid path with a volume that is substantially the same when it is in either an open mode (i.e., permitting fluid flow, also referred to as “open position”) or a closed mode (i.e., preventing fluid flow, also referred to as “closed position”). More specifically, a portion of the fluid path is formed from a resilient member disposed over a stationary member. When transitioning from the closed mode toward the open mode, the resilient member both expands radially and compresses longitudinally. This expansion and contraction is sized and configured to ensure that the overall volume within the fluid path remains substantially constant as the valve transitions from the closed mode to the open mode. In a similar manner, when retracting back to the closed mode, the resilient member operates in an opposite manner, thus further maintaining the fluid path volume. Details of this and related embodiments are discussed below.
In other embodiments, the valve produces a positive, distally directed pressure (i.e., toward its outlet) when a nozzle or syringe is withdrawn. Such pressure should prevent fluid from being drawn into the valve at such time. To these ends, the expandable member is sized and configured to expand the fluid path volume as the valve transitions toward the open mode, and reduce the fluid path volume as the valve transitions toward the closed mode. Details of this and related embodiments also are discussed below.
The valve 10 illustratively is a swabbable, luer activated valve. The top surface of the valve mechanism thus should be substantially flush with, or extend slightly outwardly from, the proximal port 12. As known by those in the art, this arrangement permits the top surface of the valve mechanism to be easily cleaned with a swab or other cleaning apparatus. In other embodiments, however, the valve 10 is not a swab valve.
Among other things, the valve 10 includes a unitary housing 18 that is coupled with a hollow post member 20 terminating at a convex proximal portion. The interior of the housing is contoured to provide the anti-drawback effect with different types of nozzles. Specifically, the interior is contoured to have a tapering proximal region 22 to accept a nozzle, and a longitudinally adjacent, distally diverging region 24. The proximal region 22 illustratively is contoured to accept various types of nozzles, such as those complying with ISO/ANSI standards (e.g., lures complying with ISO/ANSI standards). In addition to the proximal and diverging regions 22 and 24, the interior also has a central region 26 having a significantly larger inner dimension than that of the diverging region 24.
The valve interior contains a resilient, compressible and stretchable member (hereinafter “gland 28”) that, in conjunction with the post member 20, controls fluid flow through the valve 10. In illustrative embodiments, the gland 28 is secured within the valve 10 between an interior ledge 30 of the housing 18 and a radial surface 32 of the post member 20. Details of the interaction of the post member 20 and the gland 28 are discussed below.
In the embodiment shown in
The gland 28 is the only movable part within the interior of the valve 10. To that end, the gland 28 has a swabbable seal section 38 having a normally closed slit 40 therethrough, and a tubular section 42 extending from the seal section 38 to its base. When closed, the volume formed by the gland 28 and the post member 20 is considered to be a closed volume. As noted below, this volume is no longer considered to be closed after the gland 28 is urged distally a sufficient amount so that the slit 40 opens or the transverse channel 34 is not occluded. This volume is referred to herein as the “variable volume region.” It is anticipated, however, that principles of various embodiments can be applied to other types of variable volume regions, such as those formed by other or additional components. Accordingly, discussion of the noted variable volume region is exemplary and not intended to limit all embodiments of the invention.
The tubular section 42 has two sub-sections; namely, 1) a normally hollow proximal tube section 44 that, when in the closed mode, is proximal of the post member 20, and 2) a distal tube section 46 normally substantially circumscribing and flush against the post member 20. Due to a radially compressive force against the post member 20 (e.g., an interference fit), the distal tube section 46 normally occludes the transverse channel 34, consequently acting as a second seal when in the closed mode. In addition to the seal and tubular sections 38 and 42, the gland 28 also has an attachment section 48 secured between the post member 20 and housing 18 (as noted above).
When closed, which is its normal state, the valve 10 uses its two redundant seals to prevent fluid communication between the proximal and distal ports 12 and 16. Specifically, the gland 28 prevents fluid flow through the transverse channel 34, while the slit 40 prevents fluid flow through the seal section 38. In some embodiments, the gland/transverse channel seal can withstand higher backpressures than those that the slit 40 can withstand.
Insertion of a nozzle against the surface surrounding the slit 40 at the proximal end of the gland 28 opens the valve 10. Specifically, insertion of the nozzle causes the seal and tubular sections 38 and 42 of the gland 28 to both compress and move distally. Consequently, the slit 40 opens and the seal section 38 both axially compresses and radially expands. In a similar manner, the tubular section 42 both axially compresses and radially expands into/within the central region 26 of the valve interior. At some point in the transition from the closed mode to the open mode, the tubular section 42 no longer contacts (i.e., no longer occludes) the transverse channel 34, consequently fully opening the valve 10. Those in the art can configure the radially inward pressure of the gland 28 (at the transverse channel 34) so that the valve 10 opens after the nozzle has been inserted a pre-specified amount.
When open, the variable volume region is considered to have an “open volume,” which is based upon noted axial compression and radial expansion. In a corresponding manner, when closed, the variable volume region is considered to have a “closed volume.” In illustrative embodiments, the materials and dimensions of the gland 28 are selected to ensure that 1) both the open and closed volumes are substantially equal, or 2) the open volume is greater than the closed volume.
Because, in this embodiment, other regions of the fluid path are substantially constant, the total volume for containing fluid within the fluid path of the valve 10 changes in a manner that corresponds to the variable volume region. Accordingly, if volume of the variable volume region increases, the overall volume of the fluid path increases. In a similar manner, if the volume of the variable volume region decreases, the overall volume of the fluid path decreases.
When the open and closed volumes are substantially equal, there should be no appreciable net positive or negative pressure at the distal port 16 during the stroke of the nozzle as it is withdrawn (i.e., the “withdrawal stroke”). In particular, it is anticipated that during the withdrawal stroke, the variable volume region may not maintain an exactly constant volume—it may fluctuate. In such case, at certain points during the withdrawal stroke, the distal port 16 may draw in small amounts of fluid. At other points during the withdrawal stroke, however, the distal port 16 may expel small amounts of fluid. In either case, there may be some negligible reflux and positive expulsion of fluid from the distal port 16. Various embodiments with substantially equal open and closed volumes, however, ensure that the net fluid in or out of the distal port 16 (i.e., the net amount of fluid during the entire withdrawal stroke) is no greater than a negligible amount. In some embodiments, the valve 10 can be configured to ensure that the volumes remain substantially constant at least after the transverse channel 34 is opened.
Conversely, when the open volume is greater than the closed volume, a positive pressure develops at the distal port 16 when the nozzle is withdrawn. Accordingly, in that case, an appreciable amount of fluid within the valve 10 is expelled from the distal port 16. Expelling the fluid should prevent fluid from being drawn into the valve 10 at that time.
The valve 10 may be manufactured in accordance with conventional processes. For example, the housing 18 and post member 20 may be produced from a rigid plastic, while the gland 28 may be formed from a medical grade elastomeric material, such as silicone or rubber. Other materials having similar properties may be used, however, as long as they can perform the functions discussed herein.
During assembly, the gland 28 first may be inserted into the housing 18, and the post member 20 then may be secured to the housing 18. Other assembly methods, however, first may couple the gland 28 and post member 20 as a single (uncoupled) assembly. The assembly then may be inserted into the distal end of the housing 18. Of course, other methods of assembling the valve 10 may be used. Accordingly, discussion of specific methods are exemplary and not intended to limit the scope of various embodiments of the invention. In either case, the housing 18 and post member 20 may be secured together by conventional means, such as by a snap-fit connection. Alternatively, the housing and post member 20 may be secured together by ultrasonic welding.
The gland 28 in the embodiment shown in
In a manner similar to other embodiments, the housing portions 18 and 20 form a specially shaped interior. Specifically, the interior has a tapering proximal region 22 to accept a nozzle, a longitudinally adjacent, distally diverging region 24, and a larger central region 26. These regions illustratively are similar to those corresponding regions discussed above with reference to
The distal housing portion 15 also has a stationary, hollow post member 20 that terminates at a convex proximal portion. A hoop groove (hereinafter “groove 54”) having two through-holes illustratively is circumferentially formed around the outer surface of the post member 20. The through holes effectively form the transverse channel 34 and thus, also are identified by reference number 34. The two through-holes 34 form ports to a flow channel 36 extending through the post member 20.
In accordance with illustrative embodiments of the invention, the valve 10 also has a resilient, compressible, and stretchable gland 28 positioned about the post member 20 and secured between the proximal housing portion 13 and distal housing portion 15. More specifically, the gland 28 illustratively is positioned over the post member 20 to normally occlude fluid flow through the valve 10 when in the closed mode. To that end, the gland 28 has a sealing ridge 58 extending radially inwardly from its interior wall. To ensure a close fit with the post member 20, the sealing ridge 58 normally is in registry with the groove 54 when in the closed mode. Accordingly, the groove 54 and sealing ridge 58 are formed to be complimentarily shaped to close the two through-holes 34 when mated.
To ensure a secure fit between the sealing ridge 58 and groove 54, the gland 28 is secured within the housing interior in a manner that normally applies a radially inward pre-load force. To that end, the sealing ridge 58 is a part of a sealing ring 60 that normally is compressibly secured between the proximal and distal housing portions 13 and 15. Moreover, the sealing ring 60 normally is under a radially compressive force that ensures a secure fit within the groove 54, thus occluding fluid flow through the two through-holes 34. The amount of radial force can be selected during design to ensure that this portion of the valve 10 effectively forms a high pressure seal that can withstand relatively large back pressures (e.g., those higher pressures that may occur during anticipated use, such as pressures up to or greater than about 60 p.s.i.). Other embodiments, however, eliminate the pre-load.
In illustrative embodiments, the gland 28 also has a seal section 38 that normally is flush with, or extends slightly above, the inlet 12 of the valve 10. Accordingly, in a manner similar to other embodiments, the valve 10 is considered to be a “swabbable” luer activated valve. The seal section 38 is configured to act as a low pressure seal. More specifically, the seal section 38 has a normally closed slit 40. When inserted into the inlet 12, a nozzle or syringe deforms the seal section 38, consequently opening the low pressure seal.
In various embodiments discussed herein, the slit 40 is normally closed when the gland 28 is not mounted within the housing 14. No radial force thus is required (by the housing 14) to close the slit 40. In fact, in some embodiments, the outer dimension of the seal section 38 is smaller than the inner dimension of the inlet 12. In alternative embodiments, however, the inner dimension of the inlet 12 is smaller than the outer dimension of the seal section 38 of the gland 28. Consequently, in such embodiments, the housing 14 squeezes the seal section 38, thereby forcing the slit 40 closed. Those skilled in the art may shape the inlet 12 to ensure closure of the slit 40 when the valve 10 is in the closed mode.
As noted above, it is anticipated that the high pressure seal can withstand relatively high pressures. Accordingly, due to the performance of the high pressure seal, it is not necessary for the low pressure seal (i.e., the slit 40 through the seal section 38) to resist large back pressures. In some embodiments, however, the low pressure seal also may be formed to resist relatively high back pressures.
In addition to the seal section 38 and sealing ring 60, the gland 28 also has a main section 62 extending distally from the somewhat loosely defined distal end of the seal section 38 to a proximally facing interior surface of the housing 14. In fact, the sealing ring 60 extends radially outwardly from the main section 62 of the gland 28. The valve 10 thus has a fluid path with two portions; namely, a dynamic portion 64 primarily formed by the gland 28 (i.e., the variable volume region), and a static portion 66 partially formed by the post member 20. More specifically, the dynamic portion 64 generally includes the region formed between the gland 28 and the post member 20. This portion 50 thus extends from the slit 40, through the gland main section 62 to the two through-holes 34 in the post member 20, and to the base of the housing interior. The static portion 66 extends from the interior of the post member 20 to the outlet 16. In other words, the lumen through the post member 20 forms the static portion 66.
In a manner similar to other embodiments discussed above, the main section 62 of the gland 28 is both longitudinally compressible and radially expandable to vary the volume of the dynamic portion 64 of the fluid path. In particular, when a nozzle (e.g., a luer) is inserted into the inlet 12, the seal section 38 of the gland 28 collapses to deform the slit 40 (as noted above). At the same time, however, the main section 62 of the gland 28 should both longitudinally compress and radially expand. When a sufficient amount of radial force is applied to the gland main section 62, the sealing ridge 58 moves radially outwardly from its registration contact with the groove 54. In other words, when the radial force at the sealing ring 60 is equal to or slightly greater than the pre-loaded, radially inward compressive force applied by the sealing ring 60, the sealing ridge 58 moves radially outwardly from occluding contact with the through-holes 34. Consequently, the two through-holes 34 open, thus permitting fluid flow through the valve 10.
As noted above, in some embodiments, the compressive and expansive operation of the gland 28 (in response to an inserted nozzle) causes the shape of the dynamic portion 64 of the flow path to change. Although its shape changes, neutral embodiments are configured to ensure that the net volume of the dynamic portion 64 remains substantially constant as the valve 10 transitions between open and closed modes. To that end, the amount of clearance between the interior wall of the proximal housing portion 13 is selected as a function of the anticipated compressive properties of the gland 28. As a result, the outlet 16 should not develop a non-negligible positive or negative pressure and thus, eliminate non-negligible fluid drawback.
In alternative embodiments, although the interior volume of the dynamic portion 64 of the fluid path is substantially the same at both the open and closed positions, it may fluctuate as the valve 10 transitions between such positions. In yet other embodiments, the interior volume is greater when the valve 10 is in the open position than when it is in the closed position. In such case, the valve 10 produces a distally directed positive pressure through the outlet 16 when closing. Accordingly, in such embodiment, fluid is forced out through the outlet 16 as the valve 10 moves toward the closed position.
In some embodiments, the interior volume of the gland 28 depends upon the depth of penetration of the nozzle. Specifically, the internal volume may remain substantially constant to a specified depth within the valve 10. Further distally directed insertion, however, may cause the internal gland volume to increase. In yet other embodiments, depending upon the longitudinal depth of the nozzle, the interior volume of the valve 10 may have both specified amounts of fluid drawback and distally directed fluid pressure at different times during its travel between open and closed positions. Stops (not shown) may be inserted in the interior of the housing 14 to limit the insertion depth of a nozzle.
The gland 28 should operate as intended by properly selecting the various gland and housing design parameters. For example, among other things, the gland durometer and flexibility (modulus) are selected to coordinate with the appropriate gland and housing dimensions, thus providing the desired end performance. Iterative testing processes also can be used to fine tune gland performance. Computer simulation tools can further enhance the testing process. For example, the performance of the gland 28 can be modeled by finite element software (“FEA” software), such as ABAQUS EXPLICIT FEA software, distributed by Abaqus East LLC of Warwick, R.I.
In use, it is anticipated that the neutral design (i.e., the design where the gland 28 maintains substantially the same volume as it transitions between positions) may have some error factor that causes negligible amounts of fluid drawback or positive push through its outlet 16. Such negligible amounts, however, only should have negligible impact on the general goals of a neutral design.
Moreover, some embodiments may coat the interior of the housing 14 with a conventionally available anti-bacterial coating to further protect its sterility. Alternatively, conventional anti-bacterial material can be incorporated directly into the housing or gland materials.
Some embodiments of the invention have more than the three noted components (i.e., proximal housing portion 13, distal housing portion 15 with integrated post member 20, and gland 28). For example, the valve 10 also may include a gland securing member 80 within its interior to further secure the sealing ring 60 within its interior. Of course, illustrative embodiments integrate such member into the distal housing portion 15.
Accordingly, in illustrative embodiments, radial inward stress (also referred to in the art as “hoop stress”) applied to the sealing ridge 58 normally occludes fluid flow through the valve 10. Moreover, the volume of the dynamic portion 64 of the fluid path substantially eliminates fluid drawback through the valve 10.
Among other things, the valve 10 includes a housing 14 containing a resilient, compressible, and stretchable gland 28. More specifically, the housing 18 includes a proximal housing portion 13 coupled with a distal housing portion 15 incorporating a post member 20. Any conventional coupling means may be used, such as ultrasonic welding or conventional snap-fit techniques. The gland 28 and post member 20 cooperate to control fluid flow through the valve 10. In illustrative embodiments, the gland 28 is secured within the valve 10 between the two housing portions. Details of the interaction of the post member 20 and the gland 28 are discussed below.
In the embodiment shown in
In a manner similar to other embodiments, the gland 28 is the only movable part within the interior of the valve 10. To that end, the gland 28 has a swabbable seal section 38 having a normally closed slit 40 therethrough, a main section 62 extending from the seal section 38 to its base, and a radial attachment section 48 that secures the gland 28 within the valve 10. In accordance with illustrative embodiments of the invention, the main section 62 has a relatively thick main wall 70 with a plurality of radially protruding lobes 72. The lobes 72 preferably have thinner walls than those of the main section 62 (i.e., the main walls 70). Consequently, the lobes 72 should expand with less resistance than the main wall 70. Accordingly, the lobes 72 should radially expand a greater distance than that of the main section walls 70. Details of this portion of the gland 28 are discussed in greater detail below.
The main section 62 of the gland 28 also has an occluding portion 74 that normally occludes the transverse channel 34, consequently acting as the noted second seal when in the closed mode. The valve 10 thus has two seal areas; namely, the seal at the transverse channel 34 and the slit 40 in the seal section 38. Accordingly, when closed, which is its normal state, the valve mechanism uses its two redundant seals to prevent fluid communication between the proximal and distal ports 12 and 16. Specifically, when closed, the gland 28 prevents fluid flow through the transverse channel 34, while the slit 40 prevents fluid flow through the seal section 38.
In some embodiments, the gland/transverse channel seal can withstand higher backpressures than those that the slit 40 can withstand. To that end, the occluding portion 74 may be formed to have about a 0.010 inch interference fit against the post member 20. In addition to enabling the valve 10 to withstand higher backpressures, the fit of the occluding portion 74 against the post member 20 also should be selected to open the transverse channel 34 at an appropriate point in the opening stroke of the valve 10.
Insertion of a nozzle against the slit 40 at the proximal end of the gland 28 causes the seal section 38 to both compress and move distally. Consequently, the slit 40 opens and the seal section 38 both axially compresses and radially expands. In a similar manner, the main section 62 both axially compresses and radially expands. Specifically, the lobes 72 radially expand, while the main walls 70 radially expand much less significantly.
It is anticipated, however, that the lobes 72 attain a maximum volume before the nozzle is fully inserted into the valve 10. After that point, the lobes 72 axially compress to some extent, which may produce some positive pressure from the interior of the lobes 72. In a corresponding manner, when withdrawing the nozzle from full insertion, it is anticipated that the lobes 72 actually may expand to some extent before contracting. Accordingly, during nozzle withdrawal, some negative pressure may draw fluid into the valve 10. Despite these imperfections, it is anticipated that the lobes 72 ultimately will produce the desired anti-drawback effect by the time the nozzle is fully withdrawn from the valve 10. The negative impact of the noted lobe compression thus is expected to have a negligible effect on the overall operation of the valve 10.
At some point in the transition from the closed mode to the open mode, the occluding portion 74 of the gland 28 no longer contacts (i.e., no longer occludes) the transverse channel 34, consequently fully opening the valve 10. When open, the volume of the variable volume region is based upon the noted gland axial compression and radial expansion. In illustrative embodiments, the materials and dimensions of the gland 28 are selected to ensure that 1) both the open and closed volumes are substantially equal, or 2) the open volume is greater than the closed volume.
When the volumes are substantially equal, there should be no appreciable positive or negative net pressure at the distal port 16 when the nozzle is withdrawn. Accordingly, in such case, only negligible amounts of fluid drawback or distally directed pressure, if any, should occur. Conversely, when the open volume is greater than the closed volume, a net positive pressure develops at the distal port 16 when the nozzle is withdrawn. Accordingly, in that case, an appreciable amount of fluid within the valve 10 is expelled from the distal port 16. Expelling the fluid should prevent fluid from being drawn into the valve 10 at that time.
The valve 10 may be manufactured in accordance with conventional processes. In a manner similar to other embodiments, the housing 14 and post member 20 may be produced from a rigid plastic, while the gland 28 may be formed from a medical grade elastomeric material, such as silicone or rubber. Moreover, the post member 20 may be a separate piece inserted into the outlet portion of the housing 14, as shown in
Although the above discussion discloses various exemplary embodiments of the invention, it should be apparent that those skilled in the art can make various modifications that will achieve some of the advantages of the invention without departing from the true scope of the invention.
|Patente citada||Fecha de presentación||Fecha de publicación||Solicitante||Título|
|US2594405||24 Ene 1946||29 Abr 1952||Red Jacket Mfg Co||Pressure maintaining device|
|US2693801||8 Ene 1951||9 Nov 1954||Forcman Joseph||Safety cutoff valve for liquid administering apparatus|
|US2705501||9 Abr 1953||5 Abr 1955||Cincinnati Shaper Co||Non-repeat valve|
|US2756740||30 Abr 1954||31 Jul 1956||Deane William V||Drinking device for hospital patients|
|US2899975||22 Ene 1957||18 Ago 1959||Fluid pressure regulating valve|
|US2999499||11 Jul 1958||12 Sep 1961||Cutter Lab||Flexible check valve|
|US3087492||29 Dic 1960||30 Abr 1963||May L Chester||Valved catheters|
|US3105511||10 Ago 1961||1 Oct 1963||Cordis Corp||Infusion safety valve|
|US3192949||10 Jul 1962||6 Jul 1965||Halkey Roberts Corp||Spring biased check valve|
|US3385301||11 Oct 1965||28 May 1968||American Hospital Supply Corp||Balloon catheter having a deformable one-way inflation valve|
|US3399677||1 Jul 1966||3 Sep 1968||Goodrich Co B F||Catheter and valve therefor|
|US3416567||12 Feb 1965||17 Dic 1968||Viggo Ab||Syringe valve|
|US3506005||23 Feb 1967||14 Abr 1970||Arthur S Gilio||Pressure infusion device for medical use|
|US3538950||16 Abr 1969||10 Nov 1970||Locking Devices Inc||Quick connect lugged coupling|
|US3570484||20 Ago 1968||16 Mar 1971||Eschmann Bros & Walsh Ltd||Intravenous valve assembly|
|US3572375||5 Mar 1968||23 Mar 1971||David Rosenberg||Twin valve t-connector|
|US3726282||30 Sep 1971||10 Abr 1973||Kendall & Co||Inflation valve for catheter retention balloon|
|US3806086||15 Mar 1973||23 Abr 1974||Nosco Plastics||Automatic shut-off valve for administration of sterile fluids|
|US3831629||24 Ene 1972||27 Ago 1974||Halkey Roberts Corp||Check valve|
|US3838843 *||10 Jul 1972||1 Oct 1974||Pro Medical Eng Ab||Coupling means for use with blood sampling apparatus|
|US3923065||9 Sep 1974||2 Dic 1975||Jerome Nozick||Embolectomy catheter|
|US3965910||28 Abr 1975||29 Jun 1976||Walpak Company||Urinary irrigation valve|
|US3994293||29 Abr 1975||30 Nov 1976||Crinospital S.P.A.||Injector assembly for use in transfusions and perfusions|
|US4063555||22 Ene 1976||20 Dic 1977||Aktiebolaget Stille-Werner||Cannula assembly|
|US4080965||30 Sep 1976||28 Mar 1978||Baxter Travenol Laboratories, Inc.||In-line cannula valve assembly|
|US4094195||25 Feb 1977||13 Jun 1978||Waters Associates, Inc.||Novel seal and apparatus including same|
|US4094196||25 Feb 1977||13 Jun 1978||Waters Associates, Inc.||Sample injection with automatic cleaning of sampling conduit|
|US4116201||20 Dic 1976||26 Sep 1978||The Kendall Company||Catheter with inflation control device|
|US4121585||24 Ene 1977||24 Oct 1978||Becker Jr Karl E||Anti backflow injection device|
|US4143853||14 Jul 1977||13 Mar 1979||Metatech Corporation||Valve for use with a catheter or the like|
|US4223808||21 Jul 1978||23 Sep 1980||Spray Safe Company, Inc.||Refillable dispensing device having wiper seal|
|US4300571||27 Jul 1979||17 Nov 1981||Medex Inc.||Constant flush device|
|US4324239||20 Jun 1980||13 Abr 1982||Whitman Medical Corp.||Safety valve for preventing air embolism and hemorrhage|
|US4334551||30 Abr 1979||15 Jun 1982||Becton Dickinson & Company||Connector|
|US4344435||15 Dic 1978||17 Ago 1982||Aubin Norbert T||Method and surgically implantable apparatus for providing fluid communication with the interior of the body|
|US4387879||16 Jul 1981||14 Jun 1983||Eduard Fresenius Chemisch Pharmazeutische Industrie Kg||Self-sealing connector for use with plastic cannulas and vessel catheters|
|US4401432||26 May 1982||30 Ago 1983||Boris Schwartz||Storage, mixing and filtering receptacle for syringe|
|US4496348||29 Nov 1979||29 Ene 1985||Abbott Laboratories||Venipuncture device|
|US4498658||7 Sep 1982||12 Feb 1985||Nitto Kohki Co., Ltd.||Pipe coupler arrangement|
|US4534758||15 Jul 1983||13 Ago 1985||Eli Lilly & Company||Controlled release infusion system|
|US4535820||24 May 1984||20 Ago 1985||Burron Medical Inc.||Normally closed check valve|
|US4550785||29 May 1979||5 Nov 1985||Consolidated Technologies Corporation||Hammer|
|US4551136||11 Abr 1983||5 Nov 1985||Medex, Inc.||Pressure infusor|
|US4585435||31 May 1984||29 Abr 1986||The Telescope Folding Furniture Co., Inc.||Extension set for drug delivery|
|US4596557||26 Jun 1984||24 Jun 1986||Pexa Charles E||Air eliminator for intravenous tube|
|US4611973||6 Sep 1983||16 Sep 1986||P & B Industries||Pumping system and method of operating the same|
|US4617015||10 Ago 1984||14 Oct 1986||Halkey-Roberts Corporation||Visual pressure indicator for endotracheal cuff|
|US4661110||13 May 1985||28 Abr 1987||Sherwood Medical Company||Multiple passage connector fitting for a medical tube|
|US4675003||23 Dic 1985||23 Jun 1987||Cordis Corporation||Three stage pressure regulator valve|
|US4681132||23 May 1986||21 Jul 1987||Halkey-Roberts Corporation||Check valve with preset cracking pressure|
|US4683905||15 Ene 1986||4 Ago 1987||Duffour Et Igon S.A. (D.I.)||Fluid distribution connector, in particular for hospitals|
|US4683916||25 Sep 1986||4 Ago 1987||Burron Medical Inc.||Normally closed automatic reflux valve|
|US4698061||18 Abr 1986||6 Oct 1987||Baxter Travenol Laboratories, Inc.||Injection site package|
|US4710168||13 May 1986||1 Dic 1987||Egon Schwab||Non-return valve for medical purposes in particular for balloon catheters|
|US4712583||27 May 1986||15 Dic 1987||Pacesetter Infusion, Ltd.||Precision passive flat-top valve for medication infusion system|
|US4743235||5 Sep 1986||10 May 1988||Medex, Inc.||Flush control device|
|US4745950||11 Abr 1986||24 May 1988||Fresenius Ag||Connector for peritoneal dialysis|
|US4749003||22 Ene 1987||7 Jun 1988||Filtertek, Inc.||Center flow check valve|
|US4752287||30 Dic 1986||21 Jun 1988||Bioresearch, Inc.||Syringe check valve|
|US4752292||9 Ene 1987||21 Jun 1988||Icu Medical, Inc.||Medical connector|
|US4758224||26 May 1987||19 Jul 1988||Siposs George G||Suction control valve for left ventricle venting|
|US4776369||24 Feb 1987||11 Oct 1988||Halkey-Roberts Corporation||Check valve having snap-on clamping sleeve|
|US4809679||13 Oct 1987||7 Mar 1989||Olympus Optical Co., Ltd.||Forceps plug for endoscopes|
|US4816020||28 Sep 1987||28 Mar 1989||Sherwood Medical Company||Retainer device for attaching members to flexible tubes and the like to flexible tubes and the like|
|US4819684||24 Mar 1987||11 Abr 1989||Intermedicat Gmbh||Injection shut-off valve|
|US4830331||22 Jul 1988||16 May 1989||Vindum Jorgen O||High pressure fluid valve|
|US4850978||29 Oct 1987||25 Jul 1989||Baxter International Inc.||Drug delivery cartridge with protective cover|
|US4874377||26 May 1988||17 Oct 1989||Davis Newgard Revocable Family Living Trust||Self-occluding intravascular cannula assembly|
|US4915687||17 Feb 1989||10 Abr 1990||Sivert George A||Needleless injection port arrangement|
|US4917668||2 Feb 1989||17 Abr 1990||B.. Braun Melsungen Ag||Valve for permanent venous cannulae or for catheter insertion means|
|US4935010||9 Nov 1987||19 Jun 1990||Pharmacia Limited||Devices for sampling, drainage or infusion of liquids from or to the human or animal body|
|US4966199||8 Jun 1989||30 Oct 1990||Filtertek, Inc.||Diaphragm-type center flow check valve|
|US5006114||20 Abr 1990||9 Abr 1991||Rogers Bobby E||Medical valve assembly|
|US5041087||31 May 1990||20 Ago 1991||Loo George D H||Needle-less parenteral fluid injector|
|US5048537||15 May 1990||17 Sep 1991||Medex, Inc.||Method and apparatus for sampling blood|
|US5049128||6 Feb 1990||17 Sep 1991||Duquette Irene A||Valved infusion port|
|US5059175||9 Oct 1990||22 Oct 1991||University Of Utah Research Foundation||Implantable drug delivery system with piston actuation|
|US5065783||20 Sep 1990||19 Nov 1991||George Braddock Ogle, II||Valve with self-sealing internal cannula|
|US5080654||8 Nov 1990||14 Ene 1992||Applied Medical Technology, Inc.||Fluid injection device for intravenous delivery system|
|US5085645||15 Ago 1990||4 Feb 1992||Becton, Dickinson And Company||Apparatus and method for a catheter adapter with valve|
|US5100394||23 Oct 1989||31 Mar 1992||Baxter International Inc.||Pre-slit injection site|
|US5108380||4 Ene 1991||28 Abr 1992||B. Braun Melsungen Ag||Hub member|
|US5147333||13 May 1991||15 Sep 1992||Burron Medical Inc.||Needleless injection port with automatic backcheck valve|
|US5171230||29 Nov 1991||15 Dic 1992||Medex, Inc.||Fast flush catheter valve|
|US5199947||10 Sep 1991||6 Abr 1993||Icu Medical, Inc.||Method of locking an influent line to a piggyback connector|
|US5201715||19 Nov 1991||13 Abr 1993||Mcghan Medical Corporation||Implantable devices having ultrasonic echographic signature|
|US5203775||20 Mar 1992||20 Abr 1993||Medex, Inc.||Needleless connector sample site|
|US5215538||5 Feb 1992||1 Jun 1993||Abbott Laboratories||Connector-activated in-line valve|
|US5221271||15 Ago 1991||22 Jun 1993||Medex, Inc.||Sample site with flow directors|
|US5230706||12 Mar 1992||27 Jul 1993||Duquette Irene A||Bi-directional valve assembly used in needleless injection or infusion ports|
|US5242393||18 Jun 1992||7 Sep 1993||Becton, Dickinson And Company||Valved blunt cannula injection site|
|US5242432||26 Sep 1991||7 Sep 1993||Ivac||Needleless adapter|
|US5269771||24 Feb 1993||14 Dic 1993||Thomas Medical Products, Inc.||Needleless introducer with hemostatic valve|
|US5280876||25 Mar 1993||25 Ene 1994||Roger Atkins||Limited restriction quick disconnect valve|
|US5300034||29 Jul 1992||5 Abr 1994||Minnesota Mining And Manufacturing Company||Iv injection site for the reception of a blunt cannula|
|US5320328||9 Ago 1993||14 Jun 1994||Sherwood Medical Company||Suction control valve with vacuum breaker|
|US5330435||8 Abr 1993||19 Jul 1994||Vaillancourt Vincent L||Valve for a catheter assembly|
|US5349984||25 Ene 1993||27 Sep 1994||Halkey-Roberts Corporation||Check valve|
|US5360413||19 May 1993||1 Nov 1994||Filtertek, Inc.||Needleless access device|
|US5380306||23 Nov 1992||10 Ene 1995||Vygon||Unitary composite connector for a liquid circuit, in particular for medical applications|
|US5390898||6 Abr 1994||21 Feb 1995||Habley Medical Technology Corporation||Needleless dual direction check valve|
|US5401255||20 Jul 1993||28 Mar 1995||Baxter International Inc.||Multi-functional valve with unitary valving member and improved safety|
|US5439451||30 Nov 1994||8 Ago 1995||B. Braun Medical, Inc.||Capless medical backcheck valve|
|US5458640||5 May 1994||17 Oct 1995||Gerrone; Carmen J.||Cannula valve and seal system|
|US5465938||2 Mar 1993||14 Nov 1995||Werge; Robert W.||Universal fluid flow control|
|US5474536||25 Abr 1994||12 Dic 1995||Bonaldo; Jean M.||Medical valve|
|US5474544||22 Nov 1994||12 Dic 1995||Lynn; Lawrence A.||Luer-receiving medical valve|
|US5501426||10 May 1994||26 Mar 1996||Vernay Laboratories, Inc.||Medical coupling site valve body|
|US5509433||13 Oct 1993||23 Abr 1996||Paradis; Joseph R.||Control of fluid flow|
|US5509912||29 Dic 1994||23 Abr 1996||Vlv Associates||Connector|
|US5520666||6 Dic 1994||28 May 1996||Abbott Laboratories||Valved intravenous fluid line connector|
|US5533708||26 Ene 1995||9 Jul 1996||Vernay Laboratories, Inc.||Medical coupling site valve body|
|US5533983||6 Dic 1994||9 Jul 1996||Haining; Michael L.||Valved medical connector|
|US5549566||27 Oct 1994||27 Ago 1996||Abbott Laboratories||Valved intravenous fluid line infusion device|
|US5569209||21 Dic 1994||29 Oct 1996||Jemm Tran-Safe Systems, Inc.||Needleless transfer system|
|US5569235||21 Jun 1994||29 Oct 1996||Modern Medical Devices||Valve and valved container for use with a syringe fitting|
|US5573516||18 Sep 1995||12 Nov 1996||Medical Connexions, Inc.||Needleless connector|
|US5578059||10 Ago 1995||26 Nov 1996||Medex, Inc.||Anti-reflux valve with environmental barrier|
|US5616129||10 Mar 1995||1 Abr 1997||Nima Enterprises, Inc.||Needleless injection site|
|US5616130||22 Jun 1995||1 Abr 1997||Nima Enterprises, Inc.||Needleless injection site|
|US5620434||10 Jul 1995||15 Abr 1997||Brony; Seth K.||Medicine vial link for needleless syringes|
|US5674206||19 Jul 1996||7 Oct 1997||Benlan Inc.||Intravenous injection site having wipeable septum and valve structure|
|US5676346||29 Ago 1996||14 Oct 1997||Ivac Holdings, Inc.||Needleless connector valve|
|US5685866||4 Nov 1994||11 Nov 1997||Icu Medical, Inc.||Medical valve and method of use|
|US5694686||24 Jun 1994||9 Dic 1997||Icu Medical, Inc.||Method for assembling a medical valve|
|US5695466||23 Jul 1993||9 Dic 1997||Icu Medical, Inc.||Medical connection indicator and method of use|
|US5699821||15 Ago 1994||23 Dic 1997||Paradis; Joseph R.||Control of fluid flow|
|US5700248||15 Dic 1995||23 Dic 1997||Icu Medical, Inc.||Medical valve with tire seal|
|US5730418||30 Sep 1996||24 Mar 1998||The Kipp Group||Minimum fluid displacement medical connector|
|US5749861||26 Feb 1997||12 May 1998||Industrie Borla S.P.A.||Connector with protection valve for medical infusion/transfusion lines and the like|
|US5806831||28 Nov 1994||15 Sep 1998||Paradis; Joseph R.||Control of fluid flow with internal cannula|
|US5814024||27 Nov 1996||29 Sep 1998||Elcam Plastics||Needleless valve|
|US5820601||20 Ago 1996||13 Oct 1998||Critical Device Corporation||Needleless injection site|
|US5921264||28 Ago 1997||13 Jul 1999||Paradis; Joseph R.||Swabbable needleless valve|
|US6029946||15 Sep 1997||29 Feb 2000||Tiva Medical Inc.||Needleless valve|
|US6036171||19 Oct 1998||14 Mar 2000||Halkey-Roberts Corporation||Swabbable valve assembly|
|US6039302||13 Sep 1999||21 Mar 2000||Nypro Inc.||Swabbable luer-activated valve|
|US6048335||5 Mar 1998||11 Abr 2000||Becton Dickinson & Co.||Needleless injection site|
|US6050978 *||9 May 1997||18 Abr 2000||Becton Dickinson And Company||Needleless valve connector|
|US6063062||18 Abr 1997||16 May 2000||Paradis; Joseph R.||Universal luer activatable and swabbable antireflux valve|
|US6068011||22 Oct 1997||30 May 2000||Paradis; Joseph R.||Control of fluid flow|
|US6079432||2 Jul 1996||27 Jun 2000||Paradis; Joseph R.||Control of fluid flow by oval shaped valve member containing a cam interface|
|US6089541||10 Sep 1998||18 Jul 2000||Halkey-Roberts Corporation||Valve having a valve body and a deformable stem therein|
|US6142446||20 Nov 1998||7 Nov 2000||Alaris Medical Systems, Inc.||Medical adapter having needleless valve and sharpened cannula|
|US6152900||4 Nov 1998||28 Nov 2000||Becton, Dickinson And Company||Needleless injection site|
|US6228069||5 Abr 1999||8 May 2001||Filtertek Inc.||Needleless access device|
|US6245048||14 May 1998||12 Jun 2001||Icu Medical, Inc.||Medical valve with positive flow characteristics|
|US6290206||10 Ene 2000||18 Sep 2001||Alaris Medical Systems, Inc.||Needleless valve|
|US6344033||9 Ago 1999||5 Feb 2002||Baxter International, Inc.||Needleless connector|
|US6428520||4 Oct 1999||6 Ago 2002||Icu Medical, Inc.||Positive-flow valve|
|US6543745||1 Oct 2002||8 Abr 2003||Halkey-Roberts Corporation||Male luer valve|
|US6595964||22 Dic 2000||22 Jul 2003||Baxter International Inc.||Luer activated thread coupler|
|US6609696||15 Ene 2003||26 Ago 2003||Halkey-Roberts Corporation||Male luer valve|
|US6669673||5 Jun 2002||30 Dic 2003||Icu Medical, Inc.||Medical valve|
|US6802490||29 Nov 2001||12 Oct 2004||Alaris Medical Systems, Inc.||Needle free medical connector with expanded valve mechanism and method of fluid flow control|
|US7184825||8 May 2002||27 Feb 2007||Cardinal Health 303, Inc.||Needless medical connector having antimicrobial agent|
|US7914502||21 Jul 2004||29 Mar 2011||Nypro Inc.||Anti-drawback medical valve|
|US8100868||29 Oct 2010||24 Ene 2012||Nypro Inc.||Anti-drawback medical valve|
|US8529524||20 Dic 2011||10 Sep 2013||Np Medical Inc.||Anti-drawback medical valve|
|US20030050610||20 Ago 2002||13 Mar 2003||Newton Brian L.||Medical valve with expandable member|
|US20030093061||7 Nov 2002||15 May 2003||Ganem Charles F.||Anti-drawback medical valve|
|US20030098430||29 Nov 2001||29 May 2003||Leinsing Karl R.||Needle free medical connector with expanded valve mechanism and method of fluid flow control|
|US20030141477||21 Ago 2002||31 Jul 2003||Miller Pavel T.||Slit-type swabbable valve|
|US20040073171||10 Oct 2002||15 Abr 2004||Rogers Bobby E.||Needle-free valve and catheter assembly|
|US20050090805||28 Oct 2003||28 Abr 2005||Shaw Scott R.||Reconnectable disconnect device for fluid transfer line|
|US20060129109||13 Oct 2005||15 Jun 2006||Scott Randall Shaw||Reconnectable disconnect device for fluid transfer line|
|US20070218757||16 Mar 2007||20 Sep 2007||Industrie Borla S.P.A.||Valve connector for medical lines|
|US20080190485||13 Jul 2005||14 Ago 2008||Industrie Borla S.P.A.||Valve Connector For Medical Infusion Lines|
|USRE35841||11 Oct 1994||7 Jul 1998||Medex, Inc.||Needleless connector sample site|
|EP0268480A1||19 Nov 1987||25 May 1988||Pharmacia Biosystems Limited||Improvements in or relating to devices for sampling, drainage or infusion of liquids from or to the human or animal body|
|EP0629418A2||8 Sep 1993||21 Dic 1994||Filtertek, Inc.||Needleless access device|
|EP1243285A1||18 Dic 2000||25 Sep 2002||Terumo Kabushiki Kaisha||Connector|
|GB2079162A||Título no disponible|
|JP2001505087A||Título no disponible|
|JP2003144546A||Título no disponible|
|JPH10507946A||Título no disponible|
|WO1983002559A1||28 Ene 1982||4 Ago 1983||Whitman Med Corp||Safety valve for preventing air embolism or hemorrhage|
|WO1993011828A1||1 Dic 1992||24 Jun 1993||Icu Medical, Inc.||Medical valve|
|WO1996000107A1||26 Jun 1995||4 Ene 1996||Icu Medical, Inc.||Improved valve and method and apparatus for assembling|
|WO1997039791A1||22 Abr 1996||30 Oct 1997||Paradis Joseph R||Control of fluid flow|
|WO1998017192A1||25 Sep 1997||30 Abr 1998||Critical Device Corporation||Needleless injection site|
|WO1998022178A1||13 Nov 1997||28 May 1998||Nypro, Inc.||Swabbable luer-coned valve|
|WO1998026835A1||15 Dic 1997||25 Jun 1998||Icu Medical, Inc.||Positive flow valve|
|WO1998039594A1||5 Mar 1997||11 Sep 1998||Paradis Joseph R||Control of fluid flow|
|WO2000044433A2||7 Ene 2000||3 Ago 2000||Nypro, Inc.||Apparatus for reducing fluid drawback through a medical valve|
|WO2001020218A1||18 Sep 2000||22 Mar 2001||Terumo Kabushiki Kaisha||Connector|
|WO2003018104A2||20 Ago 2002||6 Mar 2003||Nypro, Inc.||Medical valve with expandable seal member|
|WO2003018105A1||1 Jul 2002||6 Mar 2003||Occupational & Medical Innovations Ltd||A valve for use with a syringe and which prevents backflow|
|WO2004060466A1||22 Dic 2003||22 Jul 2004||Alaris Medical Systems, Inc.||Safety catheter system and method|
|1||C. Valfort, Authorized officer European Patent Office, International Search Report-Application No. PCT/US2004/023367, mailed Dec. 7, 2004, together with the Written Opinion of the International Searching Authority, 14 pages.|
|2||C. Valfort, Authorized officer European Patent Office, International Search Report—Application No. PCT/US2004/023367, mailed Dec. 7, 2004, together with the Written Opinion of the International Searching Authority, 14 pages.|
|Clasificación internacional||A61M39/26, A61M39/04|
|Clasificación cooperativa||A61M2039/267, A61M39/26, A61M2039/263, A61M2039/262, A61M39/045|
|7 Feb 2014||AS||Assignment|
Owner name: NP MEDICAL INC., MASSACHUSETTS
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:NEWTON, BRIAN L.;COTE, ANDREW L., SR.;GANEM, CHARLES;ANDOTHERS;SIGNING DATES FROM 20130930 TO 20140203;REEL/FRAME:032171/0503